Coming Soon
Find information on Dry Eye Disease (DED), also known as Dry Eye Syndrome or Keratoconjunctivitis Sicca. This resource offers guidance on clinical documentation, medical coding, and healthcare best practices for diagnosing and managing dry eye. Learn about symptoms, diagnostic criteria, and treatment options for DED. Improve your understanding of Dry Eye Disease for accurate and efficient healthcare documentation and coding.
Also known as
Keratoconjunctivitis sicca
Dryness of the conjunctiva and cornea.
Keratitis
Inflammation of the cornea, sometimes associated with dry eye.
Diseases of the eye and adnexa
Encompasses various eye conditions, including dry eye.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the dry eye due to Sjogren's disease?
When to use each related code
| Description |
|---|
| Dry eyes, insufficient lubrication. |
| Inflamed cornea, often from infection. |
| Inflamed conjunctiva, various causes. |
Coding dry eye without specifying severity (mild, moderate, severe) can lead to underpayment and inaccurate quality reporting.
Failing to code associated conditions like blepharitis, MGD, or Sjogren's Syndrome impacts reimbursement and care planning.
Incorrectly coding dry eye laterality (one eye vs. both eyes) affects billing accuracy and statistical analysis.
Q: What are the most effective diagnostic tests for differentiating aqueous deficient dry eye disease from evaporative dry eye disease in clinical practice?
A: Accurately differentiating between aqueous deficient dry eye (ADDE) and evaporative dry eye (EDE) is crucial for targeted treatment. Schirmer's test, while a common initial screening tool, primarily assesses aqueous tear production and may not fully capture EDE. Tear film osmolarity measurement provides a more comprehensive assessment of tear stability and is considered a valuable marker for both ADDE and EDE. Additionally, meibography allows for visualization of meibomian gland morphology and function, aiding in the diagnosis of meibomian gland dysfunction (MGD), a major contributor to EDE. Other useful tests include tear break-up time (TBUT) and assessment of tear meniscus height. A combination of these diagnostic tests allows for a more nuanced understanding of the underlying cause of dry eye and facilitates personalized treatment strategies. Explore how integrating tear osmolarity and meibography into your dry eye assessment can improve patient outcomes.
Q: How can I effectively manage dry eye disease in patients with concurrent systemic autoimmune conditions like Sjogren's syndrome, rheumatoid arthritis, or lupus?
A: Managing dry eye disease (DED) in patients with systemic autoimmune conditions requires a comprehensive approach that addresses both the ocular surface inflammation and the underlying systemic disease. In conditions like Sjogren's syndrome, rheumatoid arthritis, and lupus, the autoimmune response can exacerbate DED, leading to more severe symptoms. Beyond artificial tears, consider implementing topical cyclosporine or lifitegrast to manage inflammation. Punctal plugs can help retain natural tears on the ocular surface, while warm compresses and lid hygiene can improve meibomian gland function, particularly in patients with evaporative dry eye. Close collaboration with the patient's rheumatologist is essential to ensure optimal management of the systemic condition and minimize its impact on ocular health. Learn more about the interplay between systemic autoimmune diseases and DED to develop effective, personalized treatment plans.
Patient presents with complaints consistent with dry eye disease (DED), also known as dry eye syndrome or keratoconjunctivitis sicca. Symptoms include ocular dryness, burning sensation, foreign body sensation, grittiness, and intermittent blurry vision. Patient reports increased discomfort in low-humidity environments, during prolonged computer use, and after extended reading. On examination, tear film breakup time (TBUT) is reduced, and corneal fluorescein staining reveals punctate epithelial erosions. Schirmer's test results indicate diminished tear production. Assessment suggests mild to moderate dry eye disease, likely contributing to the patient's reported ocular discomfort. The patient's medical history is significant for hypothyroidism, which may be a contributing factor. Current medications include levothyroxine. No known drug allergies. Diagnosis of dry eye disease is made based on patient symptoms, clinical findings, and diagnostic test results. Treatment plan includes artificial tears for symptomatic relief, education on proper eyelid hygiene including warm compresses and lid scrubs, and recommendations for environmental modifications such as increasing humidity. Patient advised to avoid prolonged screen time and take frequent breaks during visually demanding tasks. Follow-up scheduled in four weeks to assess response to treatment and consider additional therapeutic options such as punctal plugs if symptoms persist. ICD-10 code H04.123 (Unspecified keratoconjunctivitis sicca, moderate) assigned. This documentation supports medical necessity for the prescribed treatment and diagnostic testing.